Lefties Cristopher Sánchez and Jesús Luzardo give them a good place to start. Free agent Ranger Suárez could be on the way ...

Get Microsoft Office Pro 2021 for Windows plus the free training bundle for just $39.97 (MSRP $239.99) only until Oct. 19 at ...

The global economy is undergoing substantial changes, driven by fundamental shifts in trade policies. This comes at a time of deep structural transformations related to aging populations, high energy ...

You can change notification sounds for emails and calendar events directly within the new Outlook app for Windows. In classic Outlook, you can choose whether to play a sound when a new email arrives.

Fall weather has settled in. Are you ready for more? NOAA released its outlook for this winter. Meteorologist Ryan Breton breaks down what that could mean for Maine. Senate Democrats block government ...

Right now, you can get a lifetime license to Office Pro 2021 for Windows plus a complete Microsoft training bundle for just $39.97 (MSRP: $239.99). Office Pro 2021 gives you lifetime access to the ...

The International Energy Agency (IEA) has scaled back its forecast for renewable power growth to 2030, citing weaker outlooks in the United States and China. The Paris-based agency now projects total ...

While there was no shortage of concerns for investors in the third quarter of 2025, stocks powered higher on the back of the artificial intelligence boom and a long-awaited Federal Reserve interest ...

Email Assistant can help you review, organize, and draft emails. It's available to paid subscribers of Perplexity Max. AI companies are marketing heavily to enterprise customers. Perplexity is ...

Outlook shares hit record low after FDA decision FDA cites lack of substantial evidence for drug's effectiveness Company plans to meet with FDA to gain clarity on requirements Aug 28 (Reuters) - ...

Outlook Therapeutics’ second attempt to market an ophthalmic version of Roche’s tried-and-true Avastin in the U.S. has been knocked back by the FDA. In a new complete response letter, the FDA has ...